Healthpeak Properties (DOC) Stock Price, News & Analysis

Company Overview

Healthpeak Properties (NYSE: DOC) is a leading real estate investment trust focused on acquiring, developing and managing high-quality properties serving the healthcare industry. The company’s portfolio primarily comprises life science facilities, medical office buildings and senior housing communities. With a commitment to mission-critical real estate, Healthpeak partners with leading healthcare providers, academic institutions and life science companies to deliver specialized workspace and living accommodations designed to meet evolving patient care and research needs.

Founded in 1993 as Health Care REIT, the company rebranded to Healthpeak Properties in 2017 to better reflect its concentrated focus on life sciences, medical offices and senior housing. Over the years, Healthpeak has expanded its footprint across major U.S. innovation corridors, including the San Francisco Bay Area, San Diego, Boston and New York metropolitan regions. In addition to ground-up developments, the company pursues strategic acquisitions and joint ventures that enhance its exposure to high-growth sectors such as biotechnology research and cutting-edge healthcare delivery platforms.

Healthpeak’s life science assets include laboratory, office and manufacturing facilities that support the research and development activities of pharmaceutical and biotech companies. Its medical office properties are typically situated on or near hospital campuses, offering outpatient care settings for specialty practices and diagnostic services. The senior housing portfolio encompasses both owned and net-leased communities, providing a range of housing options from independent living to assisted living and memory care.

Under the leadership of President and Chief Executive Officer Michael J. DeVito Jr., Healthpeak emphasizes disciplined capital allocation, operational efficiency and long-term partnerships with tenants. The company’s experienced leadership team and board of directors bring deep expertise in real estate, healthcare and capital markets. Headquartered in Irvine, California, Healthpeak continues to pursue a focused growth strategy, leveraging its specialized asset base to deliver stable, inflation-hedged cash flows and support its mission of enhancing health and wellbeing through thoughtfully designed real estate solutions.

Key Stats

• Today's Range: $18.18 to $18.33
• 50-Day Range: $16.82 to $18.30
• 52-Week Range: $16.64 to $23.26
• Volume: 5.03 million shs
• Average Volume: 5.33 million shs
• Market Capitalization: $12.69 billion
• P/E Ratio: 45.68
• Dividend Yield: 6.68%
• Price Target: $23.27
• Consensus Rating: Moderate Buy

Healthpeak Properties Stock Analysis - MarketRank™

Healthpeak Properties scored higher than 99% of companies evaluated by MarketBeat, and ranked 14th out of 903 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Healthpeak Properties has received a consensus rating of Moderate Buy. The company's average rating score is 2.82, and is based on 9 buy ratings, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Healthpeak Properties has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: 4.84%

Earnings Growth

Earnings for Healthpeak Properties are expected to grow by 4.84% in the coming year, from $1.86 to $1.95 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Healthpeak Properties is 45.68, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.92.

Price to Earnings Ratio vs. Sector

The P/E ratio of Healthpeak Properties is 45.68, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 20.00.

Price to Earnings Growth Ratio

Healthpeak Properties has a PEG Ratio of 2.07. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Healthpeak Properties has a P/B Ratio of 1.41. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.99% of the float of Healthpeak Properties has been sold short.

Short Interest Ratio / Days to Cover

Healthpeak Properties has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Healthpeak Properties has recently increased by 39.43%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Leadership

Healthpeak Properties is a leading dividend payer. It pays a dividend yield of 6.70%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Healthpeak Properties does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Healthpeak Properties is 305.00%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on earnings estimates, Healthpeak Properties will have a dividend payout ratio of 62.56% next year. This indicates that Healthpeak Properties will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.7 / 5
• Environmental Score: -3.24

Percentage of Shares Shorted

2.99% of the float of Healthpeak Properties has been sold short.

Short Interest Ratio / Days to Cover

Healthpeak Properties has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Healthpeak Properties has recently increased by 39.43%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 4.1 / 5
• News Sentiment: 1.32

News Sentiment

Healthpeak Properties has a news sentiment score of 1.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Finance companies.

News Coverage This Week

MarketBeat has tracked 22 news articles for Healthpeak Properties this week, compared to 11 articles on an average week.

Search Interest

68 people have searched for DOC on MarketBeat in the last 30 days. This is an increase of 84% compared to the previous 30 days.

MarketBeat Follows

6 people have added Healthpeak Properties to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Healthpeak Properties insiders have bought more of their company's stock than they have sold. Specifically, they have bought $521,909.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

Only 0.23% of the stock of Healthpeak Properties is held by insiders.

Percentage Held by Institutions

93.57% of the stock of Healthpeak Properties is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

DOC Stock Analysis - Frequently Asked Questions

How have DOC shares performed this year?

Healthpeak Properties' stock was trading at $20.27 at the start of the year. Since then, DOC shares have decreased by 9.9% and is now trading at $18.27.

How were Healthpeak Properties' earnings last quarter?

Healthpeak Properties, Inc. (NYSE:DOC) announced its quarterly earnings results on Thursday, April, 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting analysts' consensus estimates of $0.46. The business's quarterly revenue was up 15.9% compared to the same quarter last year.
Read the conference call transcript.

Who are Healthpeak Properties' major shareholders?

Top institutional shareholders of Healthpeak Properties include Douglas Lane & Associates LLC (0.44%), Czech National Bank (0.02%), MFG Wealth Management Inc. (0.02%) and Mirador Capital Partners LP (0.01%). Insiders that own company stock include John T Thomas, Scott M Brinker, Tommy G Thompson, Albert Black Jr, Laurie P Becker and Bradley D Page.
View institutional ownership trends.

How do I buy shares of Healthpeak Properties?

Shares of DOC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Healthpeak Properties own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Healthpeak Properties investors own include Pfizer (PFE), Realty Income (O), Medical Properties Trust (MPW), Enterprise Products Partners (EPD), Energy Transfer (ET), Boeing (BA) and Cleveland-Cliffs (CLF).

Company Calendar

• Last Earnings: 4/24/2025
• Ex-Dividend for 5/30 Dividend: 5/19/2025
• Record date for 5/30 Dividend: 5/20/2025
• Dividend Payable: 5/30/2025
• Today: 7/10/2025
• Record date for 7/31 Dividend: 7/18/2025
• Ex-Dividend for 7/31 Dividend: 7/18/2025
• Next Earnings (Estimated): 7/24/2025
• Dividend Payable: 7/31/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Finance
• Industry: REIT - EQTY TRUST - OTHER
• Sub-Industry: Trading
• Current Symbol: NYSE:DOC
• CIK: 765880
• Web: www.docreit.com
• Phone: (414) 367-5600
• Fax: 949-407-0800
• Employees: 200
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Healthpeak Properties: $23.27
• High Price Target: $28.00
• Low Price Target: $20.00
• Potential Upside/Downside: +27.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.82
• Research Coverage: 11 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.40
• Trailing P/E Ratio: 45.68
• Forward P/E Ratio: 9.82
• P/E Growth: 2.07
• Net Income: $243.14 million
• Net Margins: 9.99%
• Pretax Margin: 10.90%
• Return on Equity: 3.06%
• Return on Assets: 1.40%

Debt

• Debt-to-Equity Ratio: 1.01
• Current Ratio: 1.35
• Quick Ratio: 1.35

Sales & Book Value

• Annual Sales: $2.70 billion
• Price / Sales: 4.70
• Cash Flow: $1.74 per share
• Price / Cash Flow: 10.53
• Book Value: $12.95 per share
• Price / Book: 1.41

Miscellaneous

• Outstanding Shares: 694,730,000
• Free Float: 693,134,000
• Market Cap: $12.69 billion
• Optionable: Optionable
• Beta: 1.03